NSV Partners III LP → Ventyx Biosciences, Inc.

Stake: 5.70% Shares: 4,089,975 CUSIP: 92332V107 Class: Common stock, par value $0.0001 per share

Item 4 — Purpose of Transaction

Item 4 of the Schedule 13D is hereby amended and supplemented by adding the following at the end of Item 4: On March 28, 2025, NSV Investments I, L.P., which holds certain shares beneficially owned by the Reporting Persons, authorized the distribution of 1,335,450 shares of Common Stock to its limited partners (the "Distribution").

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

4 13D/G filings on this issuer

3 other filings besides this one

Filer Track Record

1 filings by this filer

0 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $9.54M

Point72 Asset Mgmt

Other 13D/G Filings on Ventyx Biosciences, Inc.

Filed	Form	Filer	Stake	Shares
2026-01-09	SCHEDULE	Subramaniam Somu	5.80%	4,122,975	view →
2026-01-09	SCHEDULE	Mohan Raju	6.00%	4,387,682	view →
2023-07-11	SC	NSV Investments I, L.P.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →